FOSUY
Fosun International Limited
OTC Markets OTCPKUSDEQUITY
DELAYED
Last price
17.00
■ 0.00 (0.00%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
17.00
Day high
17.00
Day low
17.00
Volume
200
Market cap
—
P/E (TTM)
—
52W range
11.14 – 17.85
Trailing performance
Returnvs SPY
1W
0.00%
+1.1%
1M
+37.65%
+34.2%
3M
+43.46%
+41.0%
6M
+46.68%
+34.7%
YTD
+39.69%
+27.6%
1Y
-2.86%
-23.1%
3Y
+2.04%
-73.1%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Free account
3 more panels on FOSUY open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $173.43B | $192.14B | $198.20B | $182.43B | -9.7% |
| Operating revenue | $173.43B | $192.14B | $198.20B | $182.43B | -9.7% |
| Cost of revenue | $125.59B | $140.54B | $147.40B | $135.12B | -10.6% |
| Gross profit | $47.84B | $51.60B | $50.80B | $47.31B | -7.3% |
| Selling, general & admin | $44.35B | $45.65B | $49.31B | $43.57B | -2.8% |
| Total operating expense | $43.54B | $44.79B | $48.35B | $42.79B | -2.8% |
| Operating income | $4.29B | $6.81B | $2.44B | $4.52B | -36.9% |
| Net interest income | -$10.21B | -$10.02B | -$9.65B | -$7.80B | -1.8% |
| Pre-tax income | -$21.58B | $342.05M | $7.87B | $10.69B | -6,410.0% |
| Tax provision | $1.13B | $2.55B | $2.52B | $7.69B | -55.9% |
| Net income | -$23.40B | -$4.35B | $1.38B | -$831.80M | -438.0% |
| Net income to common | -$23.40B | -$4.35B | $1.38B | -$843.13M | -437.9% |
| Basic EPS | -72.00 | -13.25 | 4.25 | -2.50 | -443.4% |
| Diluted EPS | -72.00 | -13.25 | 4.25 | -2.50 | -443.4% |
| EBIT | -$9.21B | $13.07B | $19.95B | $21.17B | -170.5% |
| EBITDA | $2.33B | $23.78B | $30.50B | $30.17B | -90.2% |
| Basic shares | 324.98M | 325.42M | 326.97M | 330.60M | -0.1% |
| Diluted shares | 324.98M | 325.42M | 327.83M | 330.60M | -0.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $45.46B | $89.74B | $80.32B | $93.33B | -49.3% |
| Cash & short-term investments | $97.43B | $133.09B | $133.27B | $150.38B | -26.8% |
| Accounts receivable | $13.14B | $12.45B | $13.68B | $12.30B | +5.5% |
| Inventory | $57.44B | $67.06B | $86.53B | $97.29B | -14.3% |
| Total current assets | $234.97B | $306.79B | $325.26B | $356.91B | -23.4% |
| Property, plant & equipment | $83.72B | $81.43B | $82.91B | $69.92B | +2.8% |
| Goodwill & intangibles | $62.01B | $63.20B | $66.34B | $61.69B | -1.9% |
| Total assets | $716.23B | $796.53B | $808.39B | $806.38B | -10.1% |
| Total current liabilities | $250.50B | $328.96B | $323.53B | $362.78B | -23.9% |
| Current debt | $105.90B | $114.66B | $97.05B | $107.42B | -7.6% |
| Long-term debt | $123.94B | $107.00B | $119.15B | $120.64B | +15.8% |
| Total debt | $250.68B | $241.86B | $236.75B | $228.06B | +3.6% |
| Total liabilities | $547.93B | $598.99B | $599.81B | $607.30B | -8.5% |
| Retained earnings | $40.06B | $64.08B | $68.91B | $74.01B | -37.5% |
| Shareholder equity | $93.83B | $118.10B | $124.94B | $120.73B | -20.6% |
| Working capital | -$15.53B | -$22.17B | $1.73B | -$5.86B | +30.0% |
| Net tangible assets | $31.82B | $54.90B | $58.60B | $59.04B | -42.0% |
| Shares issued | 8.17B | 8.18B | 8.20B | 8.22B | -0.2% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$21.58B | $342.05M | $7.87B | $10.69B | -6,410.0% |
| Depreciation & amortisation | $11.54B | $10.71B | $10.56B | $9.01B | +7.8% |
| Stock-based compensation | $425.25M | $239.96M | $271.68M | $253.79M | +77.2% |
| Change in working capital | $18.10B | $13.13B | $1.24B | -$8.17B | +37.8% |
| Operating cash flow | $26.59B | $26.88B | $9.82B | $1.76B | -1.1% |
| Capital expenditure | -$11.17B | -$11.28B | -$13.17B | -$11.55B | +0.9% |
| Investing cash flow | -$61.13B | -$126.97M | $17.59B | $35.58B | -48,045.1% |
| Share buybacks | -$115.93M | -$167.25M | -$180.43M | -$543.93M | +30.7% |
| Dividends paid | -$203.18M | -$251.73M | -$35.84M | -$3.51B | +19.3% |
| Financing cash flow | -$15.25B | -$14.27B | -$39.67B | -$38.12B | -6.9% |
| Free cash flow | $15.42B | $15.61B | -$3.35B | -$9.78B | -1.2% |
| End cash position | $42.19B | $85.71B | $73.22B | $85.47B | -50.8% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
| Line item | 2025-12-31 | 2025-06-30 | 2024-12-31 | YoY |
|---|---|---|---|---|
| Cash & equivalents | $45.46B | $67.28B | $89.74B | -32.4% |
| Cash & short-term investments | $97.43B | $116.03B | $133.09B | -16.0% |
| Accounts receivable | $13.14B | $12.70B | $12.45B | +3.4% |
| Inventory | $57.44B | $64.10B | $67.06B | -10.4% |
| Total current assets | $234.97B | $251.98B | $306.79B | -6.8% |
| Property, plant & equipment | $83.72B | $84.38B | $81.43B | -0.8% |
| Goodwill & intangibles | $62.01B | $65.41B | $63.20B | -5.2% |
| Total assets | $716.23B | $735.69B | $796.53B | -2.6% |
| Total current liabilities | $250.50B | $245.61B | $328.96B | +2.0% |
| Current debt | $105.90B | $107.74B | $114.66B | -1.7% |
| Long-term debt | $123.94B | $114.37B | $107.00B | +8.4% |
| Total debt | $250.68B | $222.11B | $241.86B | +12.9% |
| Total liabilities | $547.93B | $538.35B | $598.99B | +1.8% |
| Retained earnings | $40.06B | $64.62B | $64.08B | -38.0% |
| Shareholder equity | $93.83B | $118.14B | $118.10B | -20.6% |
| Working capital | -$15.53B | $6.37B | -$22.17B | -343.7% |
| Net tangible assets | $31.82B | $52.73B | $54.90B | -39.7% |
| Shares issued | 8.17B | 8.17B | 8.18B | 0.0% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
16.98
+0.11% from price
SMA 20
14.90
+14.13% from price
SMA 50
13.37
+27.11% from price
SMA 100
12.61
+34.79% from price
SMA 200
13.27
+28.12% from price
EMA 12
16.25
+4.61% from price
EMA 26
14.99
+13.42% from price
EMA 50
13.95
+21.88% from price
RSI (14)
99.3
Overbought
MACD (12,26,9)
1.26
Hist 0.16
ATR (14)
0.33
1.95% of price
Realised vol 30D
90.0%
Annualised
Bollinger upper
19.50
20, 2σ
Bollinger lower
10.29
20, 2σ
50 / 200 cross
Golden
13.37 vs 13.27
Trend bias
Above 200
+28.12%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.04
Less volatile than market
Correlation to SPY
0.01
Largely independent
Realised vol 30D
90.0%
Annualised
Market vol 1Y
12.8%
SPY, annualised
Max drawdown 1Y
-37.6%
Peak to trough
Max drawdown 5Y
-66.6%
Peak to trough
ATR 14
0.33
1.95% of price
Beta (reported)
—
5Y monthly, from filing
Headlines
Fosun International Wins Three Awards from Global Banking & Finance Review, Gaining International Recognition for its ESG Performance, Corporate Social Responsibility, and Brand Strength
PR Newswire · 19d ago
Sector Update: Financial Stocks Advance Monday Afternoon
MT Newswires · 21d ago
Market Chatter: Apollo-Backed Athora Close to Selling German Unit to Frankfurter Leben
MT Newswires · 21d ago
Fosun International Issues Positive Profit Alert: Profit Attributable to Owners of the Parent for 1H2026 Expected to be Approx. RMB 1.5 Billion to RMB1.8 Billion
PR Newswire · 26d ago
Fosun International Garners Five Awards from Corporate Governance Asia
PR Newswire · 54d ago
Sisram Medical Investor Day Key Takeaways
PR Newswire · 89d ago
Fosun International Recognized on Fortune's 2026 "Most Admired Chinese Companies" List
PR Newswire · 89d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.